215 related articles for article (PubMed ID: 1517684)
1. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction.
Yuzbasiyan-Gurkan V; Grider A; Nostrant T; Cousins RJ; Brewer GJ
J Lab Clin Med; 1992 Sep; 120(3):380-6. PubMed ID: 1517684
[TBL] [Abstract][Full Text] [Related]
2. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
3. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis.
Brewer GJ; Dick RD; Yuzbasiyan-Gurkan V; Johnson V; Wang Y
J Lab Clin Med; 1994 Jun; 123(6):849-58. PubMed ID: 8201263
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Wilson's disease with zinc. VI. Initial treatment studies.
Brewer GJ; Yuzbasiyan-Gurkan V; Lee DY; Appelman H
J Lab Clin Med; 1989 Dec; 114(6):633-8. PubMed ID: 2592853
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
Brewer GJ; Hill GM; Dick RD; Nostrant TT; Sams JS; Wells JJ; Prasad AS
J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
[TBL] [Abstract][Full Text] [Related]
7. Zinc therapy induction of intestinal metallothionein in Wilson's disease.
Brewer GJ
Am J Gastroenterol; 1999 Feb; 94(2):301-2. PubMed ID: 10022620
[No Abstract] [Full Text] [Related]
8. The interactions of penicillamine with copper in vivo and the effect on hepatic metallothionein levels and copper/zinc distribution: the implications for Wilson's disease and arthritis therapy.
McQuaid A; Lamand M; Mason J
J Lab Clin Med; 1992 Jun; 119(6):744-50. PubMed ID: 1593220
[TBL] [Abstract][Full Text] [Related]
9. Interactions of zinc and molybdenum with copper in therapy of Wilson's disease.
Brewer GJ
Nutrition; 1995; 11(1 Suppl):114-6. PubMed ID: 7749256
[TBL] [Abstract][Full Text] [Related]
10. [Copper in the feces--a marker for the effectiveness of zinc in the treatment of Wilson's disease].
Dastych M
Z Gastroenterol; 1990 Aug; 28(8):389-91. PubMed ID: 2275259
[TBL] [Abstract][Full Text] [Related]
11. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
Günther K; Siegemund R; Lössner J; Kühn HJ
Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
[No Abstract] [Full Text] [Related]
12. [The role of zinc in the initial treatment of Wilson's disease in children].
Cacić M; Percl M; Jadresin O; Kolacek S
Lijec Vjesn; 2000 Mar; 122(3-4):77-81. PubMed ID: 10932534
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy.
Brewer GJ; Johnson VD; Dick RD; Hedera P; Fink JK; Kluin KJ
Hepatology; 2000 Feb; 31(2):364-70. PubMed ID: 10655259
[TBL] [Abstract][Full Text] [Related]
14. Wilson's disease: a new gene and an animal model for an old disease.
Cuthbert JA
J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis and treatment of Wilson's disease].
Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
[TBL] [Abstract][Full Text] [Related]
16. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
[TBL] [Abstract][Full Text] [Related]
17. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
[TBL] [Abstract][Full Text] [Related]
18. Hepatic copper and metallothionein distribution in Wilson's disease (hepatolenticular degeneration).
Nartey NO; Frei JV; Cherian MG
Lab Invest; 1987 Oct; 57(4):397-401. PubMed ID: 3312808
[TBL] [Abstract][Full Text] [Related]
19. Zinc therapy in Wilson's disease: observations in five patients.
Rossaro L; Sturniolo GC; Giacon G; Montino MC; Lecis PE; Schade RR; Corazza GR; Trevisan C; Naccarato R
Am J Gastroenterol; 1990 Jun; 85(6):665-8. PubMed ID: 2353684
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model.
Lee DY; Brewer GJ; Wang YX
J Lab Clin Med; 1989 Dec; 114(6):639-45. PubMed ID: 2592854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]